ストックスクリーナーアプリを入手
8.05
0.98%
-0.08
アフターアワーズ：
8.10
0.05
+0.62%
前日終値:
$8.13
開ける：
$8.074
24時間の取引高:
958.36K
Relative Volume:
0.49
時価総額：
$990.95M
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-12.98
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+4.55%
1か月 パフォーマンス:
-11.73%
6か月 パフォーマンス:
-48.95%
1年 パフォーマンス:
-48.06%
1日の値動き範囲:
$7.985
$8.28
1週間の範囲:
$7.3967
$8.305
52週間の値動き範囲:
$6.08
$19.11
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
8.05 | 990.95M | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
Insider Buying: Stephen Kanovsky Acquires Shares of NeoGenomics Inc (NEO) - GuruFocus
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in oncology using the UG 100 sequencing platform - Select Science
Insider Buying: Neil Gunn Acquires Shares of NeoGenomics Inc (NE - GuruFocus
Assessing NeoGenomics: Insights From 9 Financial Analysts - Benzinga
Piper Sandler Lowers Price Target on NeoGenomics (NEO) to $12.00 - GuruFocus
Piper Sandler Lowers Price Target on NeoGenomics (NEO) to $12.00 | NEO Stock News - GuruFocus
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays - Investing.com
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays - MarketBeat
NeoGenomics (NEO) Receives Adjusted Price Target from Piper Sand - GuruFocus
NeoGenomics (NEO) Receives Adjusted Price Target from Piper Sandler | NEO Stock News - GuruFocus
NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
How to Take Advantage of moves in (NEO) - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2025 Earnings Call Transcript - MSN
NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO S - GuruFocus
NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO Stock News - GuruFocus
NeoGenomics Repays $201.3 Million Convertible Senior Notes - marketscreener.com
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley - Yahoo Finance
NeoGenomics clears $201.25M convertible debt ahead of maturity By Investing.com - Investing.com India
NeoGenomics clears $201.25M convertible debt ahead of maturity - Investing.com
NeoGenomics Pays Off 1.25% Convertible Senior Notes - Yahoo Finance
NeoGenomics (NEO) Shares Drop After Disappointing Q1 Revenue Rep - GuruFocus
NeoGenomics targets 25% annual NGS growth with new product launches in 2025 - MSN
NeoGenomics (NEO) Stock Target Reduced by Morgan Stanley Amid Q1 - GuruFocus
Leerink Partners Downgrades NeoGenomics (BMV:NEO) - Nasdaq
NeoGenomics (NEO) Faces Price Target Cut Amid Significant Sellof - GuruFocus
NeoGenomics (NEO) Faces Price Target Reduction Amid Sales Challe - GuruFocus
NeoGenomics (NEO) Price Target Cut by BTIG Amid Revenue Concerns - GuruFocus
NeoGenomics stock hits 52-week low at $6.25 amid market challenges - Investing.com India
NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) (NEO) - Seeking Alpha
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - BioSpace
NeoGenomics Reports Strong Q1 2025 Performance - TipRanks
NeoGenomics (NEO) Kicks Off 2025 with Strong Revenue Momentum | - GuruFocus
NeoGenomics: Q1 Earnings Snapshot - MySA
NeoGenomics Reports Strong Q1 2025 Earnings Growth - TipRanks
NeoGenomics Q1 2025 Earnings Call Transcript - MarketBeat
NeoGenomics (NEO) Downgraded Amid Growth Concerns | NEO Stock Ne - GuruFocus
Why NeoGenomics (NEO) Stock Is Nosediving - MSN
Health Care Stocks Rise As Pfizer And AstraZeneca Lead Gains - Finimize
Fort Myers-based NeoGenomics posts $26M net loss in Q1 - Gulfshore Business
Earnings call transcript: NeoGenomics Q1 2025 revenue misses forecast, stock drops - Investing.com Nigeria
NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN
NeoGenomics stock drops on Q1 miss (NEO:NASDAQ) - Seeking Alpha
NeoGenomics Q1 2025 Financial Results: Sales Growth Amid Profitability ChallengesNews and Statistics - IndexBox
NeoGenomics Reports First Quarter 2025 Results - BioSpace
NeoGenomics and Ultima Genomics collaborate to expand clinical t - GuruFocus
NeoGenomics Inc (NEO) Q1 2025 Earnings: EPS of -$0.20 Beats Esti - GuruFocus
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
NeoGenomics Posts Q1 Breakeven Adjusted Earnings as Revenue Rises; 2025 Guidance Updated - marketscreener.com
NeoGenomics falls after Q1 sales miss - TradingView
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
0.60%
1.22%
大文字化:
|
ボリューム (24 時間):